Background loss to follow-up of HIV-positive patients before initiation of antiretroviral therapy can exceed 50% in low income settings and is a challenge to the scale-up of treatment. This observational cohort study led by National Institute of Health Director Ilesh Jani implemented point-of-care counting of CD4 cells in Mozambique and assessed the effect on loss to follow-up before immunological staging and treatment initiation.The Lancet, Vol 378, September 26, 2011. »

The Lancet remembers this leader of tropical medicine in Cuba who headed the Institute of Tropical Medicine in Cuba for more than three decades and was a founding member of IANPHI. The Lancet, Vol 378, July 23, 2011. »

For Paulo Buss, director of Brazil’s Center for Global Health at the Oswaldo Cruz Foundation (FIOCRUZ), medicine and politics have never been far apart, The former president of FIOCRUZ, founding board member of IANPHI, and host of IANPHI’s 2006 Annual Meeting is profiled for his efforts to bring better health not only to the people of Brazil, but also to the world. Stephen Pincock in Perspectives, The Lancet, Vol 377, May 22, 2011. »

These guidelines for biosafety laboratory competency outline the essential skills, knowledge, and abilities required for working with biologic agents at the three highest biosafety levels (BSL Levels 2, 3, and 4). These guidelines are intended for laboratorians working with hazardous biologic agents, obtained from either samples or specimens that are maintained and manipulated in clinical, environmental, public health, academic, and research laboratories. CDC and the Association of Public Health Laboratories in Morbidity and Mortality Weekly Report (MMWR), April 15, 2011 / 60(02);1-6 »

Without a strong public health system, how can any country respond to its biggest health challenges? IANPHI is helping low-resource countries build the infrastructure they need. Sylvia Wrobel in Emory Health Magazine, Winter 2011. »